Researchers have found a marker on head and neck tumor cells that indicates which cells are capable of fueling the cancer’s growth. The finding is the first evidence of cancer stem cells in head and neck tumors.
Cancer stem cells are the small number of cancer cells that replicate to drive tumor growth. Researchers believe current cancer treatments sometimes fail because they are not attacking the cancer stem cells. By identifying the stem cells, researchers can then develop drugs to target and kill these cells.
“Our treatment results for head and neck cancer are not as good as we’d like them to be. A lot of people still die of head and neck cancer. This finding will impact our understanding of head and neck cancer, and we hope it will lead to treatments that will be more effective,” says study author Mark Prince, M.D., assistant professor of otolaryngology at the University of Michigan Medical School and section chief of otolaryngology at the VA Ann Arbor Healthcare System.
Results of the study appear in the Jan. 16 issue of the Proceedings of the National Academy of Sciences.
Researchers at the U-M Comprehensive Cancer Center and Stanford University School of Medicine took tumor samples from patients undergoing surgery for head and neck squamous cell carcinoma, including cancers of the tongue, larynx, throat and sinus. Cells from the samples were separated based on whether they expressed a marker on their surface called CD44. The sorted cells were then implanted into immune-deficient mice to grow tumors.
The cells that expressed CD44 were able to grow new tumors, while the cells that did not express CD44 did not grow new tumors. The tumors that grew were found to be identical to the original tumors and to contain cells that expressed CD44 as well as cells that did not express the marker. This ability to both self-renew and produce different types of cells is a hallmark of stem cells.
Stem cells have been identified in several other cancer types, including breast, brain, central nervous system and colon cancers, as well as leukemia. U-M researchers in 2003 were the first to report the existence of stem cells in a solid tumor, finding them in breast cancer. CD44 was also found to play a role in breast cancer stem cells.
“We know CD44 is important in breast cancer and now in head and neck cancer, so it might be important in other cancer types. This work gives more evidence that the cancer stem cell theory is valid,” Prince says.
That theory suggests that a small subpopulation of cancer cells are the critical cells in cancer growth and progression, and the key to treating it is to kill the stem cells. It’s a radically different model than current treatment approaches, which are designed to shrink the tumor by killing as many cells as possible. Researchers suspect cancer recurs because the treatments are not killing the stem cells.
The current finding in head and neck tumors does not pinpoint the exact stem cells, the researchers believe, but rather narrows down the field. The percent of cells within a tumor expressing CD44 varied from one sample to the next, with one sample composed of as high as 40 percent of these cells. Studies in other cancer types have found the stem cell population to be smaller than 5 percent.
“The CD44-positive cells contain the tumorigenic cells, but we don’t think that’s a pure population of cancer stem cells. We still need to drill down further to find the subpopulation of those cells that is the pure version,” Prince says.
In addition to Prince, U-M study authors were doctoral student Andrew Kaczorowski and Gregory Wolf, M.D., professor and chair of otolaryngology. Stanford authors were Ranjiv Sivanandan, Michael Kaplan, M.D.; Piero Dalerba; Irving Weissman, M.D.; Michael Clarke, M.D.; and Laurie Ailles.
Funding for the study was from the U-M Specialized Program of Research Excellence (SPORE) grant in head and neck cancer and from an anonymous gift fund for cancer stem cell research at Stanford University.
While promising, this research is still in the early stages of animal testing, and more research must be done before it could benefit patients with head and neck cancer. No therapeutic treatments or clinical trials are available at this time. For information on existing options for head and neck cancer, call Cancer AnswerLine at 800-865-1125 or visit www.cancer.med.umich.edu/cancertreat/headandneck/index.shtml.
Reference: Proceedings of the NationalAcademy of Sciences, Vol. 104, No. 3, pp. 973-978
Written by Nicole Fawcett
Nicole Fawcett | EurekAlert!
Molecular libraries for organic light-emitting diodes
24.04.2017 | Goethe-Universität Frankfurt am Main
Fine organic particles in the atmosphere are more often solid glass beads than liquid oil droplets
21.04.2017 | Max-Planck-Institut für Chemie
More and more automobile companies are focusing on body parts made of carbon fiber reinforced plastics (CFRP). However, manufacturing and repair costs must be further reduced in order to make CFRP more economical in use. Together with the Volkswagen AG and five other partners in the project HolQueSt 3D, the Laser Zentrum Hannover e.V. (LZH) has developed laser processes for the automatic trimming, drilling and repair of three-dimensional components.
Automated manufacturing processes are the basis for ultimately establishing the series production of CFRP components. In the project HolQueSt 3D, the LZH has...
Reflecting the structure of composites found in nature and the ancient world, researchers at the University of Illinois at Urbana-Champaign have synthesized thin carbon nanotube (CNT) textiles that exhibit both high electrical conductivity and a level of toughness that is about fifty times higher than copper films, currently used in electronics.
"The structural robustness of thin metal films has significant importance for the reliable operation of smart skin and flexible electronics including...
The nearby, giant radio galaxy M87 hosts a supermassive black hole (BH) and is well-known for its bright jet dominating the spectrum over ten orders of magnitude in frequency. Due to its proximity, jet prominence, and the large black hole mass, M87 is the best laboratory for investigating the formation, acceleration, and collimation of relativistic jets. A research team led by Silke Britzen from the Max Planck Institute for Radio Astronomy in Bonn, Germany, has found strong indication for turbulent processes connecting the accretion disk and the jet of that galaxy providing insights into the longstanding problem of the origin of astrophysical jets.
Supermassive black holes form some of the most enigmatic phenomena in astrophysics. Their enormous energy output is supposed to be generated by the...
The probability to find a certain number of photons inside a laser pulse usually corresponds to a classical distribution of independent events, the so-called...
Microprocessors based on atomically thin materials hold the promise of the evolution of traditional processors as well as new applications in the field of flexible electronics. Now, a TU Wien research team led by Thomas Müller has made a breakthrough in this field as part of an ongoing research project.
Two-dimensional materials, or 2D materials for short, are extremely versatile, although – or often more precisely because – they are made up of just one or a...
20.04.2017 | Event News
18.04.2017 | Event News
03.04.2017 | Event News
24.04.2017 | Life Sciences
24.04.2017 | Earth Sciences
24.04.2017 | Machine Engineering